WHO ICTRP trial
A single-center phase I clinical study evaluating the pharmacokinetics and…
ChiCTR2000033326 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000033326 |
|---|---|
| Public title | A single-center phase I clinical study evaluating the pharmacokinetics and safety of single and multiple oral administration of narfurine hydrochloride Orally disintegrating tablets in Chinese healthy adult subjects |
| Scientific title | A single-center phase I clinical study evaluating the pharmacokinetics and safety of single and multiple oral administration of narfurine hydrochloride Orally disintegrating tablets in Chinese healthy adult subjects |
| Primary sponsor | The First Affiliated Hospital, Zhejiang University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Improvement of pruritus in hemodialysis patients |
| Interventions | experimental group:Nalfurafine Orally disintegrating tablets provided by Shenyang Sunshine Pharmaceutical Co., Ltd. |
| Registration date | May 28, 2020 |
| Target size | experimental group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: